Us Food And Drug Administration
-
{
- All
- News
- Videos
-
"Crucial Milestone": US Approves New Antibiotic For Urinary Tract Infections
The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and girls 12 and older.
-
Elon Musk's Neuralink Gets Go Ahead For Brain Chip Implant In 2nd Patient: Report
The US health regulator has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after it proposed to fix a problem that occurred in its first patient, the Wall Street Journal reported on Monday.
-
US Woman Enters MRI Machine With Loaded Gun, Gets Shot In Buttock Area
In an unusual incident, a woman in the United States was shot in her backside after she took a loaded gun into an MRI (magnetic resonance imagining) machine during a doctor's visit back in June.
-
Miracle Drug That Could Extend Dogs' Lives Inches Closer to Approval
A medication with the potential to prolong the lifespans of large dogs and contribute to their overall health in aging is nearing its market debut.
-
Elon Musk Expects Brain-Chip Startup Neuralink to Start First Human Trial This Year
Elon Musk expects his brain-chip startup Neuralink to start its first human trial this year, he said on Friday. While Musk didn't specify how many patients his company would implant or for how long, "it's looking like the first case will be later this year," said Musk.
-
US Food Authority Appeals US Federal Judge's Block On Abortion Pill
The US Food and Drug Administration filed an appeal on Friday against a ruling by a federal judge that overturned the approval of a safe and effective abortion pill, court records showed.
-
A TikTok Trend Sold Out Ozempic, Leaving People With Diabetes Dizzy, Scared
Ozempic, an injection that keeps blood sugar levels in check for patients with type 2 diabetes, has been in shortage for about four months, according to the database maintained by the US Food and Drug Administration.
-
US Panel Recommends Covid Vaccines For Children Under Age 5
A panel of experts convened by the US Food and Drug Administration unanimously recommended Covid-19 vaccines Wednesday for children under five, the final age group awaiting immunization in most countries.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
US Health Regulator Clears Covaxin For Clinical Trials In Adults In America
Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
-
US Health Regulator Authorizes Pfizer's Covid Pill
The US Food and Drug Administration (FDA) on Wednesday authorized Pfizer's Covid pill for high-risk people aged 12 and over, a major milestone in the pandemic that will allow millions to access the treatment.
-
Zydus Cadila Gets Final Approval From US FDA For Pre-Surgery Injection
India-based pharma giant, Zydus Cadila received final approval from US Food and Drug Administration (FDA) for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.
-
US Delays Approval For Moderna Covid Vaccine In Teenagers
US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis, or heart inflammation.
-
What To Know About COVID-19 Vaccine For US Children
The US Food and Drug Administration is considering authorizing a COVID-19 vaccine for children aged 5 to 11. The vaccine from Pfizer Inc and BioNTech SE has been available in the United States to kids aged 12 to 15 since May.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
"Crucial Milestone": US Approves New Antibiotic For Urinary Tract Infections
The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and girls 12 and older.
-
Elon Musk's Neuralink Gets Go Ahead For Brain Chip Implant In 2nd Patient: Report
The US health regulator has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after it proposed to fix a problem that occurred in its first patient, the Wall Street Journal reported on Monday.
-
US Woman Enters MRI Machine With Loaded Gun, Gets Shot In Buttock Area
In an unusual incident, a woman in the United States was shot in her backside after she took a loaded gun into an MRI (magnetic resonance imagining) machine during a doctor's visit back in June.
-
Miracle Drug That Could Extend Dogs' Lives Inches Closer to Approval
A medication with the potential to prolong the lifespans of large dogs and contribute to their overall health in aging is nearing its market debut.
-
Elon Musk Expects Brain-Chip Startup Neuralink to Start First Human Trial This Year
Elon Musk expects his brain-chip startup Neuralink to start its first human trial this year, he said on Friday. While Musk didn't specify how many patients his company would implant or for how long, "it's looking like the first case will be later this year," said Musk.
-
US Food Authority Appeals US Federal Judge's Block On Abortion Pill
The US Food and Drug Administration filed an appeal on Friday against a ruling by a federal judge that overturned the approval of a safe and effective abortion pill, court records showed.
-
A TikTok Trend Sold Out Ozempic, Leaving People With Diabetes Dizzy, Scared
Ozempic, an injection that keeps blood sugar levels in check for patients with type 2 diabetes, has been in shortage for about four months, according to the database maintained by the US Food and Drug Administration.
-
US Panel Recommends Covid Vaccines For Children Under Age 5
A panel of experts convened by the US Food and Drug Administration unanimously recommended Covid-19 vaccines Wednesday for children under five, the final age group awaiting immunization in most countries.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
US Health Regulator Clears Covaxin For Clinical Trials In Adults In America
Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
-
US Health Regulator Authorizes Pfizer's Covid Pill
The US Food and Drug Administration (FDA) on Wednesday authorized Pfizer's Covid pill for high-risk people aged 12 and over, a major milestone in the pandemic that will allow millions to access the treatment.
-
Zydus Cadila Gets Final Approval From US FDA For Pre-Surgery Injection
India-based pharma giant, Zydus Cadila received final approval from US Food and Drug Administration (FDA) for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.
-
US Delays Approval For Moderna Covid Vaccine In Teenagers
US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis, or heart inflammation.
-
What To Know About COVID-19 Vaccine For US Children
The US Food and Drug Administration is considering authorizing a COVID-19 vaccine for children aged 5 to 11. The vaccine from Pfizer Inc and BioNTech SE has been available in the United States to kids aged 12 to 15 since May.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
